Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05778305
Status:
COMPLETED
Last Update Posted:
2023-03-21
First Post:
2023-01-29
Brief Title:
Effect of Dexmedetomidine on Left Ventricular Function in Coronary Artery Bypass Graft Surgery Outcome
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Effect of Dexmedetomidine on Stress-induced Changes in Hemodynamics and Left Ventricular Function in Coronary Artery Bypass Graft Surgery Outcome
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CABAG
Brief Summary:
50 patients of both sexes undergoing elective CABG surgery will be randomly divided into 2 groups study group Dex group and control group C to determine the effect of dexmedetomidine on the peri-operative hemodynamic changes during CABG surgery
Detailed Description:
The effect of dexmedetomidine during CABG surgery is studied regarding Ventricular function pre bypass and post bypass using the transoeophageal echo TEE post-operative by transthoracic echocardiography TTE on day of surgery and after extubation
Incidence of intraoperative and post operative ischemia and arrhythmias using Electrocardiogram ECG as well as the length of ICU and hospital stay
Incidence of intraoperative and post operative ischemia and arrhythmias using Electrocardiogram ECG as well as the length of ICU and hospital stay
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None